Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Santosh G. Tupe is active.

Publication


Featured researches published by Santosh G. Tupe.


Peptides | 2011

Antifungal activity of novel synthetic peptides by accumulation of reactive oxygen species (ROS) and disruption of cell wall against Candida albicans

Indresh Kumar Maurya; Sarika Pathak; Monika Sharma; Hina Sanwal; Preeti M. Chaudhary; Santosh G. Tupe; Mukund V. Deshpande; Virander S. Chauhan; Rajendra Prasad

In the present work, we investigated the antifungal activity of two de novo designed, antimicrobial peptides VS2 and VS3, incorporating unnatural amino acid α,β-dehydrophenylalanine (ΔPhe). We observed that the low-hemolytic peptides could irreversibly inhibit the growth of various Candida species and multidrug resistance strains at MIC(80) values ranging from 15.62 μM to 250 μM. Synergy experiments showed that MIC(80) of the peptides was drastically reduced in combination with an antifungal drug fluconazole. The dye PI uptake assay was used to demonstrate peptide induced cell membrane permeabilization. Intracellular localization of the FITC-labeled peptides in Candida albicans was studied by confocal microscopy and FACS. Killing kinetics, PI uptake assay, and the intracellular presence of FITC-peptides suggested that growth inhibition is not solely a consequence of increased membrane permeabilization. We showed that entry of the peptide in Candida cells resulted in accumulation of reactive oxygen species (ROS) leading to cell necrosis. Morphological alteration in Candida cells caused by the peptides was visualized by electron microscopy. We propose that de novo designed VS2 and VS3 peptides have multiple detrimental effects on target fungi, which ultimately result in cell wall disruption and killing. Therefore, these peptides represent a good template for further design and development as antifungal agents.


Mini-reviews in Medicinal Chemistry | 2013

Chitin Synthase Inhibitors as Antifungal Agents

Preeti M. Chaudhary; Santosh G. Tupe; Mukund V. Deshpande

Increased risk of fungal diseases in immunocompromised patients, emerging fungal pathogens, limited repertoire of antifungal drugs and resistance development against the drugs demands for development of new and effective antifungal agents. With greater knowledge of fungal metabolism efforts are being made to inhibit specific enzymes involved in different biochemical pathways for the development of antifungal drugs. Chitin synthase is one such promising target as it is absent in plants and mammals. Nikkomycin Z, a chitin synthase inhibitor is under clinical development. Chitin synthesis in fungi, chitin synthase as a target for antifungal agent development, different chitin synthase inhibitors isolated from natural sources, randomly synthesized and modified from nikkomycin and polyoxin are discussed in this review.


Biochimica et Biophysica Acta | 2013

Mechanism of action of novel synthetic dodecapeptides against Candida albicans

Indresh Kumar Maurya; Chaitanya Kumar Thota; Jyotsna Sharma; Santosh G. Tupe; Preeti M. Chaudhary; Manoj Kumar Singh; Indu Shekhar Thakur; Mukund V. Deshpande; Rajendra Prasad; Virander S. Chauhan

BACKGROUND Three de novo designed low molecular weight cationic peptides (IJ2, IJ3 and IJ4) containing an unnatural amino acid α,β-didehydrophenylalanine (∆Phe) exhibited potent antifungal activity against fluconazole (FLC) sensitive and resistant clinical isolates of Candida albicans as well as non-albicans and other yeast and filamentous pathogenic fungi. In the present study, their synthesis, susceptibility of different fungi and the mechanism of anti-candidal action have been elucidated. METHODS The antimicrobial peptides (AMPs) were synthesized by solid-phase method and checked for antifungal activity against different yeasts and fungi by broth microdilution method. Anti-candidal mode of action of the peptides was investigated through detecting membrane permeabilization by confocal microscopy, Reactive Oxygen Species (ROS) generation by fluorometry, apoptosis and necrosis by flow cytometry and cell wall damage using Scanning and Transmission Electron Microscopy. RESULTS AND CONCLUSIONS The MIC of the peptides against C. albicans and other yeast and filamentous fungal pathogens ranged between 3.91 and 250μM. All three peptides exhibited effect on multiple targets in C. albicans including disruption of cell wall structures, compromised cell membrane permeability leading to their enhanced entry into the cells, accumulation of ROS and induction of apoptosis. The peptides also showed synergistic effect when used in combination with fluconazole (FLC) and caspofungin (CAS) against C. albicans. GENERAL SIGNIFICANCE The study suggests that the AMPs alone or in combination with conventional antifungals hold promise for the control of fungal pathogens, and need to be further explored for treatment of fungal infections.


Bioorganic & Medicinal Chemistry Letters | 2012

Hybrid molecules of carvacrol and benzoyl urea/thiourea with potential applications in agriculture and medicine

Umesh D. Pete; Chetan M. Zade; Jitendra D. Bhosale; Santosh G. Tupe; Preeti M. Chaudhary; Amol G. Dikundwar; Ratnamala S. Bendre

Benzoyl phenyl urea, a class of insect growth regulators acts by inhibiting chitin synthesis. Carvacrol, a naturally occurring monoterpenoid is an effective antifungal agent. We have structurally modified carvacrol (2-methyl-5-[1-methylethyl] phenol) by introducing benzoylphenyl urea linkage. Two series of benzoylcarvacryl thiourea (BCTU, 4a-f) and benzoylcarvacryl urea (BCU, 5a-f) derivatives were prepared and characterized by elemental analysis, IR, (1)H and (13)C NMR and Mass spectroscopy. Derivatives 4b, 4d, 4e, 4f and 5d, 5f showed comparable insecticidal activity with the standard BPU lufenuron against Dysdercus koenigii. BCTU derivatives 4c, 4e and BCU 5c showed good antifungal activity against phytopathogenic fungi viz. Magnaporthe grisae, Fusarium oxysporum, Dreschlera oryzae; food spoilage yeasts viz. Debaromyces hansenii, Pichia membranifaciens; and human pathogens viz. Candida albicans and Cryptococcus neoformans. Compounds 5d, 5e and 5f showed potent activity against human pathogens. Moderate and selective activity was observed for other compounds. All the synthesized compounds were non-haemolytic. These compounds have potential application in agriculture and medicine.


ACS Medicinal Chemistry Letters | 2015

Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation

Gorakhnath R. Jachak; Remya Ramesh; Duhita G. Sant; Shweta U. Jorwekar; Manjusha R. Jadhav; Santosh G. Tupe; Mukund V. Deshpande; D. Srinivasa Reddy

Known morpholine class antifungals (fenpropimorph, fenpropidin, and amorolfine) were synthetically modified through silicon incorporation to have 15 sila-analogues. Twelve sila-analogues exhibited potent antifungal activity against different human fungal pathogens such as Candida albicans, Candida glabrata, Candida tropicalis, Cryptococcus neoformans, and Aspergillus niger. Sila-analogue 24 (fenpropimorph analogue) was the best in our hands, which showed superior fungicidal potential than fenpropidin, fenpropimorph, and amorolfine. The mode of action of sila-analogues was similar to morpholines, i.e., inhibition of sterol reductase and sterol isomerase enzymes of ergosterol synthesis pathway.


Natural Product Research | 2014

Antifungal dimeric chalcone derivative kamalachalcone E from Mallotus philippinensis.

Roshan R. Kulkarni; Santosh G. Tupe; Suwarna P. Gample; Macchindra G. Chandgude; Dhiman Sarkar; Mukund V. Deshpande; Swati P. Joshi

From the red coloured extract (Kamala) prepared through acetone extraction of the fresh whole uncrushed fruits of Mallotus philippinensis, one new dimeric chalcone (1) along with three known compounds 1-(5,7-dihydroxy-2,2,6-trimethyl-2H-1-benzopyran-8-yl)-3-phenyl-2-propen-1-one (2), rottlerin (3) and 4′-hydroxyrottlerin (4) were isolated. The structure of compound 1 was elucidated by 1D and 2D NMR analyses that included HSQC, HMBC, COSY and ROESY experiments along with the literature comparison. Compounds 1–4 were evaluated for antifungal activity against different human pathogenic yeasts and filamentous fungi. The antiproliferative activity of the compounds was evaluated against Thp-1 cell lines. Compounds 1 and 2 both exhibited IC50 of 8, 4 and 16 μg/mL against Cryptococcus neoformans PRL518, C. neoformans ATCC32045 and Aspergillus fumigatus, respectively. Compound 4, at 100 μg/mL, showed 54% growth inhibition of Thp-1 cell lines.


Journal of Applied Microbiology | 2016

Fungal cell membrane-promising drug target for antifungal therapy.

Duhita G. Sant; Santosh G. Tupe; Chepuri V. Ramana; Mukund V. Deshpande

Increase in invasive fungal infections over the past few years especially in immunocompromised patients prompted the search for new antifungal agents with improved efficacy. Current antifungal armoury includes very few effective drugs like Amphotericin B; new generation azoles, including voriconazole and posaconazole; echinocandins like caspofungin and micafungin to name a few. Azole class of antifungals which target the fungal cell membrane are the first choice of treatment for many years because of their effectiveness. As the fungal cell membrane is predominantly made up of sterols, glycerophospholipids and sphingolipids, the role of lipids in pathogenesis and target identification for improved therapeutics were largely pursued by researchers during the last few years. Present review focuses on cell membrane as an antifungal target with emphasis on membrane biogenesis, structure and function of cell membrane, cell membrane inhibitors, screening assays, recent advances and future prospects.


RSC Advances | 2016

Re-engineering of PIP3-antagonist triazole PITENIN's chemical scaffold: development of novel antifungal leads

Sravani Pulya; Yadagiri Kommagalla; Duhita G. Sant; Shweta U. Jorwekar; Santosh G. Tupe; Mukund V. Deshpande; Chepuri V. Ramana

A novel 4-(1-phenyl-1-hydroxyethyl)-1-(o-hydroxyphenyl)-1H-1,2,3-triazole was designed by integrating the structural features of triazole PITENIN anticancer agents and the azole class of antifungal drugs. A two-step protocol comprising the Barbier propargylation and Cu-catalyzed azide–alkyne cycloaddition was established to synthesise a diverse set of compounds of this class. Their screening against a wide range of human fungal pathogens led to identification of several potential antifungal hits and some of them displayed better antifungal activity than fluconazole against Candida glabrata, Cryptococcus neoformans, Aspergillus fumigatus and Aspergillus niger. Mode of action studies revealed that their antifungal activity was resulting either from the inhibition of lanosterol 14 α-demethylase enzyme (leading to ergosterol depletion) or by the generation of reactive oxygen species (ROS).


Archive | 2017

Diversity of Natural Yeast Flora of Grapes and Its Significance in Wine Making

Sarika S. Mane; Vandana Ghormade; Santosh G. Tupe; Mukund V. Deshpande

The biodiversity of yeasts associated with grapes has been studied in different regions of wine producing countries throughout the world. Most of the species associated with the wine environment are similar, while some species are specifically associated with specific regions. Though Saccharomyces cerevisiae is primarily used for fermentation of grape juice, its occurrence is low on grape berries. Non-Saccharomyces yeasts belonging to the genera Torulaspora, Hanseniaspora, Pichia, Candida, Issatchenkia, Metschnikowia etc. are in abundance in grape musts and may dominate the early stages of fermentation. Subsequently, S. cerevisiae proliferates, becomes dominant and completes the wine fermentation. Therefore, yeasts diversity associated with the grapes and must significantly contribute to the quality and varietal character of wine. In present review, the diversity of yeasts associated with vineyard, winery, succession of yeasts during fermentation and their role in wine quality is discussed. The knowledge will be useful to monitor and control the fermentation with respect to quality and spoilage.


Mini-reviews in Medicinal Chemistry | 2018

Facile and Solvent-free Domino Synthesis of New Quinolidinyl-2,4- thiazolidinones: Antifungal Activity and Molecular Docking

Dnyaneshwar D. Subhedar; Mubarak H. Shaikh; Santosh G. Tupe; Mukund V. Deshpande; Vijay M. Khedkar; Prakash C. Jha; Bapurao B. Shingate

OBJECTIVE We have synthesized new quinolidinyl-thiazolidinones via Knoevenagel condensation- alkylation reaction, catalyzed by [Et3NH][HSO4]. The present approach offers several advantages such as higher yields, eco-friendly reaction condition and economic availability of the catalyst. METHOD The newly synthesized compounds were evaluated for their in vitro antifungal activity against six fungal strains. Some of the synthesized conjugates displayed good to moderate antifungal activity. CONCLUSION Again, the molecular docking study performed against the fungal sterol 14α-demethylase (CYP51) showed an excellent binding affinity towards the enzyme which could rationalize the promising antifungal activity portrayed by these derivatives and provides a platform for structure based drug design.

Collaboration


Dive into the Santosh G. Tupe's collaboration.

Top Co-Authors

Avatar

Mukund V. Deshpande

Indian Institute of Chemical Technology

View shared research outputs
Top Co-Authors

Avatar

Duhita G. Sant

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Preeti M. Chaudhary

Indian Institute of Chemical Technology

View shared research outputs
Top Co-Authors

Avatar

Chepuri V. Ramana

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Shweta U. Jorwekar

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Dhiman Sarkar

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Gorakhnath R. Jachak

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rajendra Prasad

Amity Institute of Biotechnology

View shared research outputs
Top Co-Authors

Avatar

Remya Ramesh

Council of Scientific and Industrial Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge